A decade of optimizing drug development for rare neuromuscular disorders through TACT
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Nature reviews. Drug discovery - 19(2020), 1 vom: 06. Jan., Seite 1-2 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wagner, Kathryn R [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 13.04.2020 Date Revised 10.12.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1038/d41573-019-00199-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM305069284 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM305069284 | ||
| 003 | DE-627 | ||
| 005 | 20231225120351.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/d41573-019-00199-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1016.xml |
| 035 | |a (DE-627)NLM305069284 | ||
| 035 | |a (NLM)31907422 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wagner, Kathryn R |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A decade of optimizing drug development for rare neuromuscular disorders through TACT |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.04.2020 | ||
| 500 | |a Date Revised 10.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a News | |
| 700 | 1 | |a De Luca, Annamaria |e verfasserin |4 aut | |
| 700 | 1 | |a Caizergues, Didier |e verfasserin |4 aut | |
| 700 | 1 | |a Dowling, James |e verfasserin |4 aut | |
| 700 | 1 | |a Goemans, Nathalie |e verfasserin |4 aut | |
| 700 | 1 | |a Gordish-Dressman, Heather |e verfasserin |4 aut | |
| 700 | 1 | |a Grounds, Miranda D |e verfasserin |4 aut | |
| 700 | 1 | |a Kelly, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Mayhew, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a McNally, Elizabeth M |e verfasserin |4 aut | |
| 700 | 1 | |a Zoetis, Tracey |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Joanne |e verfasserin |4 aut | |
| 700 | 1 | |a Turner, Cathy |e verfasserin |4 aut | |
| 700 | 1 | |a Wells, Dominic J |e verfasserin |4 aut | |
| 700 | 1 | |a Csimma, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Straub, Volker |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature reviews. Drug discovery |d 2002 |g 19(2020), 1 vom: 06. Jan., Seite 1-2 |w (DE-627)NLM119883511 |x 1474-1784 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2020 |g number:1 |g day:06 |g month:01 |g pages:1-2 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/d41573-019-00199-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2020 |e 1 |b 06 |c 01 |h 1-2 | ||